These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37885391)

  • 1. [In vitro Activity of Rifabutin and Clofazimine to Macrolide-Resistant Mycobacterium abscessus Complex Clinical Isolates].
    Sürücüoğlu S; Özkütük N; Gazi H; Çavuşoğlu C
    Mikrobiyol Bul; 2023 Oct; 57(4):639-649. PubMed ID: 37885391
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of drug-susceptibility patterns and gene sequences associated with clarithromycin and azithromycin resistance in
    Yoshida S; Tsuyuguchi K; Kobayashi T; Inoue Y; Suzuki K
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33570485
    [No Abstract]   [Full Text] [Related]  

  • 4. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
    Ruedas-López A; Tato M; Broncano-Lavado A; Esteban J; Ruiz-Serrano MJ; Sánchez-Cueto M; Toro C; Domingo D; Cacho J; Barrado L; López-Roa P
    Microbiol Spectr; 2023 Jun; 11(3):e0504122. PubMed ID: 37212700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species.
    Jong BE; Wu TS; Chen NY; Yang CH; Shu CC; Wang LS; Wu TL; Lu JJ; Chiu CH; Lai HC; Chung WH
    Microbiol Spectr; 2022 Dec; 10(6):e0274922. PubMed ID: 36416559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Identification of Strains within the
    Kania K; Wόjcik K; Czekajewska J; Grzesiak M; Klesiewicz K
    Pol J Microbiol; 2023 Dec; 72(4):491-506. PubMed ID: 38103008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and drug susceptibility profiles of Mycobacterium abscessus complex infection at a medical school in Thailand.
    Sukmongkolchai S; Petsong S; Oudomying N; Prommi A; Payungporn S; Usawakidwiree W; Wongjarit K; Suwanpimolkul G; Faksri K; Suankratay C; Rotcheewaphan S
    Ann Clin Microbiol Antimicrob; 2023 Sep; 22(1):87. PubMed ID: 37735687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
    Nash KA; Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1367-76. PubMed ID: 19171799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex.
    Rubio M; March F; Garrigó M; Moreno C; Español M; Coll P
    PLoS One; 2015; 10(10):e0140166. PubMed ID: 26448181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of rifabutin against Mycobacterium abscessus, clinical isolates.
    Chen J; Zhang H; Guo Q; He S; Xu L; Zhang Z; Ma J; Chu H
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):767-775. PubMed ID: 35531776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between the genotypes and phenotypes of clarithromycin-resistant
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):413-418. PubMed ID: 29562989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Arghittu M; Girelli D; Biffi A; D'Accico M; Daccò V; Gambazza S; Pizzamiglio G; Trovato A; Tortoli E; Colombo C; Cariani L
    New Microbiol; 2020 Jul; 43(3):127-132. PubMed ID: 32656572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.
    Brown-Elliott BA; Vasireddy S; Vasireddy R; Iakhiaeva E; Howard ST; Nash K; Parodi N; Strong A; Gee M; Smith T; Wallace RJ
    J Clin Microbiol; 2015 Apr; 53(4):1211-5. PubMed ID: 25653399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.
    Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
    J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.
    Choi GE; Shin SJ; Won CJ; Min KN; Oh T; Hahn MY; Lee K; Lee SH; Daley CL; Kim S; Jeong BH; Jeon K; Koh WJ
    Am J Respir Crit Care Med; 2012 Nov; 186(9):917-25. PubMed ID: 22878281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Mycobacterium abscessus Pulmonary Disease.
    Griffith DE; Daley CL
    Chest; 2022 Jan; 161(1):64-75. PubMed ID: 34314673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.